Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface

Dry eye disease (DED) is a chronic ocular surface disorder, associated with inflammation, which can cause severe morbidity, visual compromise, and loss of quality of life, affecting up to 5–50% of the world population. In DED, ocular surface damage and tear film instability due to abnormal tear secr...

Full description

Bibliographic Details
Main Authors: Nallathambi Jeyabalan, Aswathi M Pillai, Pooja Khamar, Rohit Shetty, Rajiv R Mohan, Arkasubhra Ghosh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=4;spage=1285;epage=1291;aulast=Jeyabalan
_version_ 1827944876304498688
author Nallathambi Jeyabalan
Aswathi M Pillai
Pooja Khamar
Rohit Shetty
Rajiv R Mohan
Arkasubhra Ghosh
author_facet Nallathambi Jeyabalan
Aswathi M Pillai
Pooja Khamar
Rohit Shetty
Rajiv R Mohan
Arkasubhra Ghosh
author_sort Nallathambi Jeyabalan
collection DOAJ
description Dry eye disease (DED) is a chronic ocular surface disorder, associated with inflammation, which can cause severe morbidity, visual compromise, and loss of quality of life, affecting up to 5–50% of the world population. In DED, ocular surface damage and tear film instability due to abnormal tear secretion lead to ocular surface pain, discomfort, and epithelial barrier disruption. Studies have shown the involvement of autophagy regulation in dry eye disease as a pathogenic mechanism along with the inflammatory response. Autophagy is a self-degradation pathway in mammalian cells that reduces the excessive inflammation driven by the secretion of inflammatory factors in tears. Specific autophagy modulators are already available for the management of DED currently. However, growing studies on autophagy regulation in DED might further encourage the development of autophagy modulating drugs that reduce the pathological response at the ocular surface. In this review, we summarize the role of autophagy in the pathogenesis of dry eye disease and explore its therapeutic application.
first_indexed 2024-03-13T10:36:27Z
format Article
id doaj.art-d7d0e4947d6645648c20b835150843a7
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-03-13T10:36:27Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-d7d0e4947d6645648c20b835150843a72023-05-18T05:50:42ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892023-01-017141285129110.4103/IJO.IJO_2912_22Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surfaceNallathambi JeyabalanAswathi M PillaiPooja KhamarRohit ShettyRajiv R MohanArkasubhra GhoshDry eye disease (DED) is a chronic ocular surface disorder, associated with inflammation, which can cause severe morbidity, visual compromise, and loss of quality of life, affecting up to 5–50% of the world population. In DED, ocular surface damage and tear film instability due to abnormal tear secretion lead to ocular surface pain, discomfort, and epithelial barrier disruption. Studies have shown the involvement of autophagy regulation in dry eye disease as a pathogenic mechanism along with the inflammatory response. Autophagy is a self-degradation pathway in mammalian cells that reduces the excessive inflammation driven by the secretion of inflammatory factors in tears. Specific autophagy modulators are already available for the management of DED currently. However, growing studies on autophagy regulation in DED might further encourage the development of autophagy modulating drugs that reduce the pathological response at the ocular surface. In this review, we summarize the role of autophagy in the pathogenesis of dry eye disease and explore its therapeutic application.http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=4;spage=1285;epage=1291;aulast=Jeyabalanautophagy modulatorscorneal autophagyinflammationocular surface dry eye disease
spellingShingle Nallathambi Jeyabalan
Aswathi M Pillai
Pooja Khamar
Rohit Shetty
Rajiv R Mohan
Arkasubhra Ghosh
Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
Indian Journal of Ophthalmology
autophagy modulators
corneal autophagy
inflammation
ocular surface dry eye disease
title Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
title_full Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
title_fullStr Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
title_full_unstemmed Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
title_short Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface
title_sort autophagy in dry eye disease therapeutic implications of autophagy modulators on the ocular surface
topic autophagy modulators
corneal autophagy
inflammation
ocular surface dry eye disease
url http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=4;spage=1285;epage=1291;aulast=Jeyabalan
work_keys_str_mv AT nallathambijeyabalan autophagyindryeyediseasetherapeuticimplicationsofautophagymodulatorsontheocularsurface
AT aswathimpillai autophagyindryeyediseasetherapeuticimplicationsofautophagymodulatorsontheocularsurface
AT poojakhamar autophagyindryeyediseasetherapeuticimplicationsofautophagymodulatorsontheocularsurface
AT rohitshetty autophagyindryeyediseasetherapeuticimplicationsofautophagymodulatorsontheocularsurface
AT rajivrmohan autophagyindryeyediseasetherapeuticimplicationsofautophagymodulatorsontheocularsurface
AT arkasubhraghosh autophagyindryeyediseasetherapeuticimplicationsofautophagymodulatorsontheocularsurface